Telangana unveils Next-Gen Life Sciences Policy 2026–30 in Davos; eyes $25 billion investments, 5 lakh jobs

Telangana Government unveiled the new, Next-Gen Life Sciences Policy 2026–30 at the ongoing World Economic Forum (WEF) annual meeting in Davos, that is expected to serve as a guiding framework as the State seeks to leapfrog from a scale-driven manufacturing approach to value-led, innovation-powered growth.

Target of the policy

The ambition is to position Telangana as a globally integrated Life Sciences hub across discovery, development and deployment as well as rank among the top five life sciences clusters worldwide by 2030. The policy targets $25 billion in investments, creation of five lakh high-quality jobs and deeper integration into global life sciences value chains, Industries and IT Minister D. Sridhar Babu said after Chief Minister A. Revanth Reddy and others launched the policy.

Stress on cross-border collaboration

“We are building one of the world’s most trusted and transformational biosciences ecosystems—driving global health impact from Telangana. The policy’s global unveiling at Davos reflects Telangana’s conviction that the next phase of growth in life sciences will be driven by cross-border collaboration, global capital, and shared innovation agendas,” Mr. Revanth Reddy said.

The State Government is keen on Telangana playing a far more consequential role in shaping the future of global healthcare, advanced therapeutics and sustainable bio-manufacturing. The Next-Gen Life Sciences Policy represents a deliberate scale-up, designed to accelerate Telangana’s transition from being indispensable to global supply chains to becoming a global originator of advanced therapies and platforms, the Minister’s office said.

Frontier science and advanced manufacturing platforms prioritised

“In the last two years alone, we have been able to attract investment of ₹73,000 crore. With the launch of new policy, we are now aiming higher to attract ₹2 Lakh crore over the next five years. The policy prioritises frontier science and advanced manufacturing platforms, including cell and gene therapies, peptides, precision fermentation, and other next-generation modalities,” Mr. Sridhar Babu said.

The policy will strengthen the broader ecosystem across clinical research, pharma services, diagnostics, medical electronics and digital health — positioning Telangana as a preferred destination for global life sciences hubs, he said. Special Chief Secretary Sanjay Kumar and Telangana Lifesciences CEO Shakthi M. Nagappan were present.

“The policy is not merely a framework. It is designed to accelerate adoption of breakthrough technologies such as AI, digital health and next generation therapeutics, while nurturing skilled talent. A defining reform is the recognition of R&D units as full-fledged industrial enterprises, allowing them equal access to incentives and reinforcing the State’s commitment to innovation and high-value scientific activity,” Mr. Sanjay Kumar said.

$100 million Life Sciences Innovation Fund

Mr. Nagappan said the new policy will strengthen Telangana’s integration into the global life sciences value chain. A dedicated Life Sciences Innovation Fund, scalable up to ₹1,000 crore ($100 million) will catalyse early- and growth-stage innovation, support deep-tech ventures – particularly biotherapeutics. Another key initiative proposed is the establishment of the Telangana School of Life Sciences, a university of global excellence focused on research, education, and future-ready talent development.

The policy implementation will be anchored by globally benchmarked infrastructure, including the Green Pharma City, ten Pharma Villages, expansion of Genome Valley and further strengthening of the Medical Devices Park.